291 related articles for article (PubMed ID: 30666436)
1. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
Jin B; Liu H
J Neurol; 2019 Oct; 266(10):2363-2375. PubMed ID: 30666436
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis.
Tricco AC; Ashoor HM; Soobiah C; Rios P; Veroniki AA; Hamid JS; Ivory JD; Khan PA; Yazdi F; Ghassemi M; Blondal E; Ho JM; Ng CH; Hemmelgarn B; Majumdar SR; Perrier L; Straus SE
J Am Geriatr Soc; 2018 Jan; 66(1):170-178. PubMed ID: 29131306
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and acceptability of treatments for depressive symptoms in cognitive impairment: A systematic review and Bayesian network meta-analysis.
Jin B; Xv Y; Zhang B; Qiao L; Liu H
Front Aging Neurosci; 2022; 14():1037414. PubMed ID: 36578447
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis.
Huang YY; Teng T; Shen XN; Chen SD; Wang RZ; Zhang RQ; Dou KX; Zhong XL; Wang J; Chen KL; Zhao QH; Tan L; Dong Q; Zhou XY; Yu JT
Ageing Res Rev; 2022 Mar; 75():101568. PubMed ID: 35051646
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis.
Jin BR; Liu HY
Neural Regen Res; 2019 May; 14(5):805-816. PubMed ID: 30688266
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis.
Veroniki AA; Ashoor HM; Rios P; Seitidis G; Stewart L; Clarke M; Tudur-Smith C; Mavridis D; Hemmelgarn BR; Holroyd-Leduc J; Straus SE; Tricco AC
BMJ Open; 2022 Apr; 12(4):e053012. PubMed ID: 35473731
[TBL] [Abstract][Full Text] [Related]
9. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
[TBL] [Abstract][Full Text] [Related]
10. Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis.
Watt JA; Goodarzi Z; Veroniki AA; Nincic V; Khan PA; Ghassemi M; Thompson Y; Lai Y; Treister V; Tricco AC; Straus SE
BMC Geriatr; 2020 Jun; 20(1):212. PubMed ID: 32546202
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
[TBL] [Abstract][Full Text] [Related]
13. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Rodda J; Morgan S; Walker Z
Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of multiple non-pharmacological interventions for behavioural and psychological symptoms of dementia: A network meta-analysis of randomised controlled trials.
Yin Z; Li Y; Bao Q; Zhang X; Xia M; Zhong W; Wu K; Yao J; Chen Z; Sun M; Zhao L; Liang F
Int J Ment Health Nurs; 2024 Jun; 33(3):487-504. PubMed ID: 38012101
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Yan Y; Yang X; Wang M; Chen B; Yin L; Ma X
Psychol Med; 2022 Sep; 52(12):2224-2231. PubMed ID: 35993319
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis.
Huang YY; Teng T; Giovane CD; Wang RZ; Suckling J; Shen XN; Chen SD; Huang SY; Kuo K; Cai WJ; Chen KL; Feng L; Zhang C; Liu CY; Li CB; Zhao QH; Dong Q; Zhou XY; Yu JT
Age Ageing; 2023 Jun; 52(6):. PubMed ID: 37381843
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
20. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
